Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,532 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Platinum pathway.
Marsh S, McLeod H, Dolan E, Shukla SJ, Rabik CA, Gong L, Hernandez-Boussard T, Lou XJ, Klein TE, Altman RB. Marsh S, et al. Pharmacogenet Genomics. 2009 Jul;19(7):563-4. doi: 10.1097/FPC.0b013e32832e0ed7. Pharmacogenet Genomics. 2009. PMID: 19525887 Free PMC article. No abstract available.
Cytochrome P450 2C9-CYP2C9.
Van Booven D, Marsh S, McLeod H, Carrillo MW, Sangkuhl K, Klein TE, Altman RB. Van Booven D, et al. Among authors: marsh s. Pharmacogenet Genomics. 2010 Apr;20(4):277-81. doi: 10.1097/FPC.0b013e3283349e84. Pharmacogenet Genomics. 2010. PMID: 20150829 Free PMC article. Review. No abstract available.
PharmGKB summary: fluoropyrimidine pathways.
Thorn CF, Marsh S, Carrillo MW, McLeod HL, Klein TE, Altman RB. Thorn CF, et al. Among authors: marsh s. Pharmacogenet Genomics. 2011 Apr;21(4):237-42. doi: 10.1097/FPC.0b013e32833c6107. Pharmacogenet Genomics. 2011. PMID: 20601926 Free PMC article. No abstract available.
Doxorubicin pathways: pharmacodynamics and adverse effects.
Thorn CF, Oshiro C, Marsh S, Hernandez-Boussard T, McLeod H, Klein TE, Altman RB. Thorn CF, et al. Among authors: marsh s. Pharmacogenet Genomics. 2011 Jul;21(7):440-6. doi: 10.1097/FPC.0b013e32833ffb56. Pharmacogenet Genomics. 2011. PMID: 21048526 Free PMC article. No abstract available.
Taxane pathway.
Oshiro C, Marsh S, McLeod H, Carrillo MW, Klein T, Altman R. Oshiro C, et al. Among authors: marsh s. Pharmacogenet Genomics. 2009 Dec;19(12):979-83. doi: 10.1097/FPC.0b013e3283335277. Pharmacogenet Genomics. 2009. PMID: 21151855 Free PMC article. No abstract available.
PharmGKB summary: methotrexate pathway.
Mikkelsen TS, Thorn CF, Yang JJ, Ulrich CM, French D, Zaza G, Dunnenberger HM, Marsh S, McLeod HL, Giacomini K, Becker ML, Gaedigk R, Leeder JS, Kager L, Relling MV, Evans W, Klein TE, Altman RB. Mikkelsen TS, et al. Among authors: marsh s. Pharmacogenet Genomics. 2011 Oct;21(10):679-86. doi: 10.1097/FPC.0b013e328343dd93. Pharmacogenet Genomics. 2011. PMID: 21317831 Free PMC article. No abstract available.
Pharmacogenetics of irinotecan toxicity.
Marsh S, McLeod HL. Marsh S, et al. Pharmacogenomics. 2004 Oct;5(7):835-43. doi: 10.1517/14622416.5.7.835. Pharmacogenomics. 2004. PMID: 15469406 Review.
Pharmacogenomic assessment of carboxylesterases 1 and 2.
Marsh S, Xiao M, Yu J, Ahluwalia R, Minton M, Freimuth RR, Kwok PY, McLeod HL. Marsh S, et al. Genomics. 2004 Oct;84(4):661-8. doi: 10.1016/j.ygeno.2004.07.008. Genomics. 2004. PMID: 15475243
Polymorphism discovery in 51 chemotherapy pathway genes.
Freimuth RR, Xiao M, Marsh S, Minton M, Addleman N, Van Booven DJ, McLeod HL, Kwok PY. Freimuth RR, et al. Among authors: marsh s. Hum Mol Genet. 2005 Dec 1;14(23):3595-603. doi: 10.1093/hmg/ddi387. Epub 2005 Oct 20. Hum Mol Genet. 2005. PMID: 16239245
1,532 results